查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2046710

羊膜製品市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、最終用戶、地區和競爭對手分類，2021-2031年

Amniotic Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By End-User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球羊膜產品市場預計將從 2025 年的 9.5123 億美元大幅成長至 2031 年的 14.6231 億美元，複合年成長率為 7.43%。

該市場涵蓋人類胎盤來源的生物移植物和液體同種異體移植物，因其在創傷護理、整形外科和眼科領域具有再生和抗炎特性而備受重視。這一成長主要受慢性傷口（例如糖尿病足潰瘍）發病率上升以及需要高級組織修復的老年人口不斷成長的推動。例如，根據美國捐贈生命組織（Donate Life America）預測，2024年將進行超過250萬例組織移植手術，凸顯了移植組織產品在術後恢復中的關鍵作用。儘管需求強勁，但該市場在監管分類方面仍面臨諸多障礙。更嚴格的監管指南模糊了微加工組織和複雜生物製藥之間的界線。這種監管上的模糊性使產品分類和研發進度複雜化，並可能因報銷和市場准入困難而延緩新型羊膜療法的推出。

市場概覽
預測期 2027-2031
市場規模：2025年 9.5123億美元
市場規模：2031年 1,462,310,000 美元
複合年成長率：2026-2031年 7.43%
成長最快的細分市場 冷凍保存的羊膜
最大的市場 北美洲

市場促進因素

全球羊膜產品市場的主要驅動力是慢性傷口和糖尿病傷口的日益普遍，這促使人們對先進的再生醫學產生了迫切需求。糖尿病足潰瘍和靜脈性腿部潰瘍等疾病，由於年齡成長和糖尿病患病率上升而加劇，尤其需要富含生長因子的羊膜同種異體移植來促進組織癒合。這種臨床需求直接轉化為顯著的商業性成長，例如，Smith+Nephew公司的高級傷口生物活性產品部門報告稱，其2024年第四季度和全年銷售額成長了20.3%，這主要得益於皮膚替代物銷售額的成長。此外，MiMedx集團報告稱，其2024年全年淨銷售額為3.49億美元，反映出其胎盤衍生性創傷護理產品的廣泛應用。同時，羊膜在整形外科和運動醫學的應用不斷擴大，也推動了市場成長。在這些領域，臨床醫生正在使用這些生物材料來治療肌腱炎和足底筋膜炎等軟組織損傷。它們天然的抗炎和抗粘連特性，透過改善手術效果和縮短恢復時間，推動了該領域的快速成長。 Organogenesis Holdings Inc. 的外科與運動醫學部門在 2025 年第三季錄得 904 萬美元的銷售額，年增 25%。這表明，隨著骨科醫生擴大採用非鴉片類生物製藥，該領域正在成為重要的收入來源。

市場挑戰

全球羊膜產品市場成長的主要限制因素是監管分類的不確定性日益加劇，以及由此導致的報銷結構變化。監管機構正在對微加工組織和複雜生物製藥進行更嚴格的區分，並施加繁瑣的合規流程，這不可避免地會延緩產品上市。這種監管轉變也推動了支付政策的變化，從高額的單次報銷轉向一次性或固定金額支付。這些轉變顯著壓縮了利潤空間，使許多公司難以在財務上生產先進的羊膜同種異體移植產品，並阻礙了對新產品創新的投資。這些報銷限制正在產生明顯而嚴重的財務影響。例如，美國醫療保險和醫療補助服務中心（CMS）已設定2025年12月起皮膚替代品的固定支付價格為每平方公分127.14美元。組織庫協會（AATB）認為，對於許多組織庫而言，這一單價“在經濟上是不永續的”，並警告稱，如此嚴格的價格上限會威脅到生產商的生存。這種財務壓力迫使企業縮減產品系列，進而阻礙市場擴張，並限制患者獲得必要的再生醫學治療。

市場趨勢

一個關鍵的市場趨勢是，真空乾燥和凍乾羊膜產品擴大被採用，用於室溫儲存，從而解決了傳統冷凍保存組織固有的物流和低溫運輸難題。這種轉變正在改變供應鏈，為醫療機構提供高度穩定的移植物，這些移植物可在室溫下隨時取用，並可立即用於緊急手術。這種兼具便利性和穩定性的產品形式正在直接推動外科領域的商業性成功。例如，MiMedx集團的外科產品類型專注於室溫儲存的脫水同種異體移植物，其2025年第二季的淨銷售額較上年同期成長了15%。同時，該產業正在拓展其在機器人輔助泌尿系統和重組手術中的應用，外科醫生使用特製的超厚羊膜移植物來增強精細組織的修復。這種應用旨在最大限度地減少粘連的形成，並改善涉及輸尿管等複雜結構的微創手術的癒合效果。 2025 年 5 月，美國泌尿系統協會在《泌尿外科雜誌》上發表了一項未來展望研究，證明了這種方法的有效性，報告稱，使用羊膜進行機器人輔助輸尿管重組一年後，88% 的患者症狀得到改善。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球羊膜產品市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（冷凍保存的羊膜、脫水羊膜）
    • 按應用領域（創傷護理、整形外科、眼科、其他）
    • 依最終使用者（醫院、門診手術中心等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美羊膜產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲羊膜產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區羊膜產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲羊膜產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲羊膜產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球羊膜產品市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • MiMedx Group, Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Holdings, Inc.
  • Amnio technology LLC
  • Alliqua Biomedical, Inc.
  • Human Regenerative Technologies, LLC
  • Corza Ophthalmology Inc.
  • BioTissue Holdings, Inc.
  • Applied Biologics LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17422

The Global Amniotic Products Market is projected to expand significantly from USD 951.23 Million in 2025 to USD 1462.31 Million by 2031, exhibiting a CAGR of 7.43%. This market encompasses biological grafts and fluid allografts sourced from the human placenta, valued for their regenerative and anti-inflammatory qualities in wound care, orthopedics, and ophthalmology. Growth is largely fueled by the increasing incidence of chronic wounds like diabetic foot ulcers and a growing elderly population requiring advanced tissue repair. For example, over 2.5 million tissue transplants were performed in 2024, as per Donate Life America, highlighting the crucial role of donated tissue products in surgical recovery. Despite this robust demand, the market faces a key hurdle in regulatory classification, with stricter guidelines from regulatory bodies blurring the lines between minimally manipulated tissues and complex biological drugs. This regulatory ambiguity complicates product categorization, development timelines, and subsequently, reimbursement and market access, potentially slowing the introduction of novel amniotic therapies.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 951.23 Million
Market Size 2031USD 1462.31 Million
CAGR 2026-20317.43%
Fastest Growing SegmentCryopreserved Amniotic Membranes
Largest MarketNorth America

Market Driver

The Global Amniotic Products Market is primarily driven by the escalating prevalence of chronic and diabetic wounds, which fuels an urgent need for advanced regenerative therapies. Conditions like diabetic foot ulcers and venous leg ulcers, exacerbated by an aging population and rising diabetes rates, specifically demand amniotic allografts rich in growth factors to expedite tissue healing. This clinical demand is directly translating into significant commercial growth, evidenced by Smith+Nephew's Advanced Wound Bioactives segment reporting 20.3% underlying revenue growth in Q4 and Full Year 2024, largely due to increased skin substitute sales. Additionally, MiMedx Group, Inc. reported $349 million in full-year net sales for 2024, reflecting broad adoption of their placental-based wound care products. Simultaneously, market expansion is bolstered by the increasing use of amniotic membranes in orthopedics and sports medicine, where clinicians employ these biologics for soft tissue injuries such as tendonitis and plantar fasciitis. Their natural anti-inflammatory and anti-adhesion properties enhance surgical outcomes and shorten recovery periods, propelling rapid growth in this segment. Organogenesis Holdings Inc.'s Surgical & Sports Medicine segment saw a 25% year-over-year revenue increase to $9.04 million in Q3 2025, underscoring this area's emergence as a key revenue source as orthopedic surgeons increasingly adopt non-opioid, biologic therapies.

Market Challenge

The primary impediment to the Global Amniotic Products Market's growth stems from mounting uncertainty in regulatory classification and subsequent changes in reimbursement structures. Regulatory bodies are drawing stricter lines between minimally manipulated tissues and complex biological drugs, imposing arduous compliance processes that invariably delay product introductions. This regulatory shift has also instigated changes in payment policies, moving from distinct high-value reimbursements to bundled or flat-rate payments. Such a transition significantly compresses profit margins, rendering the production of advanced amniotic allografts financially challenging for numerous companies and hindering investment in new product innovation. These reimbursement limitations have a clear and severe financial impact; for instance, the Centers for Medicare & Medicaid Services (CMS) finalized a flat payment rate of $127.14 per square centimeter for skin substitutes in December 2025. The American Association of Tissue Banks (AATB) deemed this rate 'economically unsustainable' for many tissue banks, cautioning that these stringent price caps threaten manufacturer viability. This financial strain compels companies to narrow their product portfolios, thereby impeding market expansion and restricting patient access to essential regenerative therapies.

Market Trends

A significant market trend involves the growing adoption of vacuum-dried and lyophilized amniotic products designed for ambient storage, addressing the logistical and cold-chain challenges inherent with traditional cryopreserved tissues. This shift is transforming supply chains by providing healthcare facilities with shelf-stable, ready-to-use grafts that are readily available at room temperature for spontaneous surgical interventions. This move towards convenient, stable configurations is directly boosting commercial success in the surgical field; for example, MiMedx Group, Inc.'s Surgical product category, heavily featuring ambient dehydrated allografts, saw a 15% year-over-year increase in net sales in Q2 2025. Concurrently, the industry is expanding its applications into robotic urological and reconstructive surgeries, where specialized, ultra-thick amniotic grafts are being incorporated by surgeons to strengthen delicate tissue repairs. This application aims to minimize adhesion formation and improve healing results in minimally invasive procedures involving intricate structures such as the ureter. A prospective study in the 'Journal of Urology', cited by the American Urological Association in May 2025, validated this approach, reporting symptomatic improvement in 88% of patients one year after robotic ureteral reconstruction using amniotic membranes.

Key Market Players

  • MiMedx Group, Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Holdings, Inc.
  • Amnio technology LLC
  • Alliqua Biomedical, Inc.
  • Human Regenerative Technologies, LLC
  • Corza Ophthalmology Inc.
  • BioTissue Holdings, Inc.
  • Applied Biologics LLC

Report Scope

In this report, the Global Amniotic Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Amniotic Products Market, By Type

  • Cryopreserved Amniotic Membranes
  • Dehydrated Amniotic Membranes

Amniotic Products Market, By Application

  • Wound Care
  • Orthopedics
  • Ophthalmology
  • Others

Amniotic Products Market, By End-User

  • Hospitals & Ambulatory Surgical Centers
  • Other

Amniotic Products Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Amniotic Products Market.

Available Customizations:

Global Amniotic Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Amniotic Products Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes)
    • 5.2.2. By Application (Wound Care, Orthopedics, Ophthalmology, Others)
    • 5.2.3. By End-User (Hospitals & Ambulatory Surgical Centers, Other)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Amniotic Products Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End-User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Amniotic Products Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-User
    • 6.3.2. Canada Amniotic Products Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-User
    • 6.3.3. Mexico Amniotic Products Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-User

7. Europe Amniotic Products Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End-User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Amniotic Products Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-User
    • 7.3.2. France Amniotic Products Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-User
    • 7.3.3. United Kingdom Amniotic Products Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-User
    • 7.3.4. Italy Amniotic Products Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-User
    • 7.3.5. Spain Amniotic Products Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-User

8. Asia Pacific Amniotic Products Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Amniotic Products Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-User
    • 8.3.2. India Amniotic Products Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-User
    • 8.3.3. Japan Amniotic Products Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-User
    • 8.3.4. South Korea Amniotic Products Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-User
    • 8.3.5. Australia Amniotic Products Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-User

9. Middle East & Africa Amniotic Products Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End-User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Amniotic Products Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-User
    • 9.3.2. UAE Amniotic Products Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-User
    • 9.3.3. South Africa Amniotic Products Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-User

10. South America Amniotic Products Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End-User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Amniotic Products Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-User
    • 10.3.2. Colombia Amniotic Products Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-User
    • 10.3.3. Argentina Amniotic Products Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Amniotic Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. MiMedx Group, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Integra LifeSciences Holdings Corporation
  • 15.3. Organogenesis Holdings, Inc.
  • 15.4. Amnio technology LLC
  • 15.5. Alliqua Biomedical, Inc.
  • 15.6. Human Regenerative Technologies, LLC
  • 15.7. Corza Ophthalmology Inc.
  • 15.8. BioTissue Holdings, Inc.
  • 15.9. Applied Biologics LLC

16. Strategic Recommendations

17. About Us & Disclaimer